Literature DB >> 10799746

Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma.

Y M Jeng1, C Y Lin, H C Hsu.   

Abstract

The c-Kit protein, a receptor type tyrosine kinase that plays an important role in the development of hematopoietic cells, melanocytes, and germ cells, is expressed in mastocytosis, gastrointestinal stromal cell tumors (GISTs), germ cell tumors, and several other tumors. Gain-of-function mutations in exon 11 and exon 17 have been shown as a mechanism of c-kit activation in some tumors. To study the role of c-kit in salivary gland carcinomas, we analyzed the c-kit protein expression in 79 carcinomas of major and minor salivary glands by immunohistochemistry. Although varying in intensity of staining, c-kit expression was identified very often in adenoid cystic carcinomas (20/25), lymphoepithelioma-like carcinomas (6/6) and myoepithelial carcinomas (2/2), but not in other types of salivary gland carcinoma (0/46), P<0.00001. By DNA sequencing, genetic alteration of c-kit juxtamembrane domain (exon 11) and tyrosine kinase domain (exon 17) was not found in all the three types of salivary carcinoma that had c-kit protein expression. In conclusion, c-kit protein overexpression is involved in the pathogenesis of certain types of salivary gland carcinoma, but mutation of the gene is not the mechanism of c-kit activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799746     DOI: 10.1016/s0304-3835(00)00387-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  36 in total

Review 1.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

Review 2.  Genetic alterations in salivary gland cancers.

Authors:  Linda X Yin; Patrick K Ha
Journal:  Cancer       Date:  2016-02-29       Impact factor: 6.860

3.  Expression of miRNAs in adenoid cystic carcinomas of the breast and salivary glands.

Authors:  Orsolya Kiss; Anna-Mária Tőkés; Semir Vranic; Zoran Gatalica; László Vass; Nóra Udvarhelyi; A Marcell Szász; Janina Kulka
Journal:  Virchows Arch       Date:  2015-08-21       Impact factor: 4.064

4.  A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.

Authors:  A L Ho; L Dunn; E J Sherman; M G Fury; S S Baxi; R Chandramohan; S Dogan; L G T Morris; G D Cullen; S Haque; C S Sima; A Ni; C R Antonescu; N Katabi; D G Pfister
Journal:  Ann Oncol       Date:  2016-08-26       Impact factor: 32.976

Review 5.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

6.  Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland.

Authors:  Lizette Vila; Hongyan Liu; Samer Z Al-Quran; Dominique P Coco; Hui-Jia Dong; Chen Liu
Journal:  Mod Pathol       Date:  2009-07-17       Impact factor: 7.842

7.  Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.

Authors:  S J Wong; T Karrison; D N Hayes; M S Kies; K J Cullen; T Tanvetyanon; A Argiris; N Takebe; D Lim; N F Saba; F P Worden; J Gilbert; H J Lenz; A R A Razak; J D Roberts; E E Vokes; E E W Cohen
Journal:  Ann Oncol       Date:  2015-11-23       Impact factor: 32.976

8.  Myoepithelial carcinoma of pharynx expressing KIT and PDGFRA.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

Review 9.  Molecular Pathology and Biomarkers.

Authors:  Patrick K Ha; Göran Stenman
Journal:  Adv Otorhinolaryngol       Date:  2016-04-12

10.  Mitochondrial mutations in adenoid cystic carcinoma of the salivary glands.

Authors:  Suhail K Mithani; Chunbo Shao; Marietta Tan; Ian M Smith; Joseph A Califano; Adel K El-Naggar; Patrick K Ha
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.